These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29181529)

  • 1. Restaging Abdominopelvic Computed Tomography Before Surgery After Preoperative Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
    Park HJ; Jang JK; Park SH; Park IJ; Kim JH; Baek S; Hong YS
    JAMA Oncol; 2018 Feb; 4(2):259-262. PubMed ID: 29181529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Liu GC; Zhang X; Xie E; An X; Cai PQ; Zhu Y; Tang JH; Kong LH; Lin JZ; Pan ZZ; Ding PR
    Medicine (Baltimore); 2015 Nov; 94(47):e2074. PubMed ID: 26632714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed tomography with histological correlation for evaluating tumor regression of rectal carcinoma after preoperative chemoradiation therapy.
    Lee CT; Chow NH; Liu YS; Lin SC; Lin PC; Wu YH; Lee JC; Tsai HM
    Hepatogastroenterology; 2012; 59(120):2484-9. PubMed ID: 22497951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine preoperative restaging CTs after neoadjuvant chemoradiation for locally advanced rectal cancer are low yield: a retrospective case study.
    Davids JS; Alavi K; Andres Cervera-Servin J; Choi CS; Sturrock PR; Sweeney WB; Maykel JA
    Int J Surg; 2014 Dec; 12(12):1295-9. PubMed ID: 25448648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of neoadjuvant chemoradiotherapy on the rates of sphincter preserving surgery in lower rectal cancer and analysis of their prognostic factors].
    Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
    Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):419-423. PubMed ID: 27938574
    [No Abstract]   [Full Text] [Related]  

  • 6. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
    Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ
    Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
    Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
    G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Preoperative Chemoradiotherapy on the Likelihood of Sphincter Preservation Surgery in Locally Advanced Distal Rectal Cancer: A Longitudinal Study Based on Pelvic Magnetic Resonance Imaging.
    Ihn MH; Kim YH; Kim DW; Oh HK; Lee SY; Park JT; Son IT; Park JH; Lee YJ; Kim JW; Lee KW; Kim JH; Shin E; Lee HS; Ahn S; Kang SB
    Ann Surg Oncol; 2015 Jul; 22(7):2159-67. PubMed ID: 25503346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preoperative diagnostic procedures in locally advanced rectal carcinoma (> or =T3 or N+). What does endoluminal ultrasound achieve at staging and restaging (after neoadjuvant radiochemotherapy) in contrast to computed tomography?].
    Liersch T; Langer C; Jakob C; Müller D; Ghadimi BM; Siemer A; Markus PM; Füzesi L; Becker H
    Chirurg; 2003 Mar; 74(3):224-34. PubMed ID: 12647079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
    Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
    Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
    Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
    Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
    Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of sequential endorectal US to predict the tumor response of preoperative chemoradiotherapy in rectal cancer.
    Li N; Dou L; Zhang Y; Jin J; Wang G; Xiao Q; Li Y; Wang X; Ren H; Fang H; Wang W; Wang S; Liu Y; Song Y
    Gastrointest Endosc; 2017 Mar; 85(3):669-674. PubMed ID: 27354104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
    Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
    World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative Value of Restaging MRI, CT, and FDG-PET Scan After Preoperative Chemoradiation for Rectal Cancer.
    Schneider DA; Akhurst TJ; Ngan SY; Warrier SK; Michael M; Lynch AC; Te Marvelde L; Heriot AG
    Dis Colon Rectum; 2016 Mar; 59(3):179-86. PubMed ID: 26855391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Is the Utility of Restaging Imaging for Patients With Clinical Stage II/III Rectal Cancer After Completion of Neoadjuvant Chemoradiation and Prior to Proctectomy?
    Hendrick LE; Buckner JD; Guerrero WM; Shibata D; Hinkle NM; Monroe JJ; Glazer ES; Deneve JL; Dickson PV
    Am Surg; 2021 Feb; 87(2):242-247. PubMed ID: 32927959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter Evaluation of Rectal cancer ReImaging pOst Neoadjuvant (MERRION) Therapy.
    Hanly AM; Ryan EM; Rogers AC; McNamara DA; Madoff RD; Winter DC;
    Ann Surg; 2014 Apr; 259(4):723-7. PubMed ID: 23744576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging in restaging rectal cancer after neoadjuvant chemoradiotherapy.
    Zhan S; Wang X; Huang X; Zhu H
    J BUON; 2015; 20(1):62-7. PubMed ID: 25778298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?
    Jaffe TA; Neville AM; Bashir MR; Uronis HE; Thacker JM
    Colorectal Dis; 2013 Nov; 15(11):e654-8. PubMed ID: 23910050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.